Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
暂无分享,去创建一个
T. Beißbarth | J. Rüschoff | L. Conradi | J. Gaedcke | H. Bohnenberger | M. Grade | T. Liersch | P. Middel | M. Ghadimi | M. Spitzner | A. König | Anna Metzger | Merle Kisly